High performance liquid chromatographic determination of sodium benzoate, methylparaben and propylparaben as preservative components in nystatin suspensions

A simple and sensitive method was developed for the analysis of preservatives sodium benzoate, methylparaben and propylparaben in nystatin suspensions by reversed-phase high performance liquid chromatography (HPLC), equipped with a C18 column and PDA detector. The mobile phase was a mixture of acetonitrile and acetate buffer of pH 4.4 (35:65 v/v). Under the optimized experimental conditions, separation of the preservatives was achieved in less than 20 min. The limits of quantifications (LOQs) and the linear dynamic ranges (LDRs) of sodium benzoate, methylparaben and propylparaben were 0.3 and 50–1000 μg Ml^?1, 0.5 and 50–600 μg ml^?1 and 0.3 and 50–900 μg ml^?1, respectively; the respective precisions (%RSD) at 500 μg ml^?1 level were 0.72%, 0.73% and 0.51% (n = 6). The average recoveries of sodium benzoate, methylparaben and propylparaben for spiked nystatin samples were obtained as 98%, 97% and 98%, respectively.     

Determination of mixtures of ampicillin and cloxacillin in pharmaceuticals by second-derivative spectrophotometry

Mixtures of ampicillin-Na and cloxacillin-Na are assayed by peak-to-baseline and zero-crossing second-derivative spectrophotometry. The procedure does not require any separation step. Calibration plots are linear (r = 0.9999) up to 30 μg ml^?1 of ampicillin-Na at 216 nm and up to 40 μg ml^?1 ampicillin-Na or cloxacillin-Na at 228 nm or 248.8 nm, respectively, in the presence of one another. Detection limits at the p = 0.05 level of significance, range from 0.15 pg ml^?1 to 0.33 μg ml^?1. The method was successfully applied to commercial injections and capsules containing these penicillins.     

Flow-Injection Chemiluminescence Determination of Fluoroquinolones

ABSTRACT

A new flow-injection CL method was developed for the determination of fluoroquinolones including ofloxacin, norfloxacin, ciprofloxacin and lomefloxacin in pharmaceutical preparations, based on the chemiluminescence reaction of sulphite with cerium(IV) sensitized by these compounds. The linear ranges are 0.04 to 4.0 μg ml^?1 for ofloxacin and 0.4 to 40.0 μg ml^?1 for norfloxacin, ciprofloxacin and lomefloxacin, respectively. The detection limits are 0.016 μg ml^?1 for ofloxacin and 0.16 μg ml ^?1 for norfloxacin, ciprofloxacin and lomefloxacin, respectively. The relative standard deviations (RSD) are 2.1 to 2.6% (n=10) for these fluoroquinolones. The analytical procedure has been applied to the determination of the fluoroquinolones in pharmaceutical commercial formulations. The results are in agreement with those obtained by the official methods.     

Direct detection of acetaminophen in urine by liquid chromatography with electrochemical detection using dual electrodes. Preliminary application to a single-dose pharmacokinetic study

A method for the direct determination of acetaminophen in urine based on liquid chromatography with series dual-electrode detection has been developed. No sample pretreatment steps are required except for filtration. The method gives a linear range from 0.5 to 300 μg ml^?1 and a detection limit of 0.2 μg ml^?1 (10 μl). The analysis time of the assay is less than 7 min. The pharmacokinetics of acetaminophen in urine from a subject who had orally ingested 450 mg (table form) of the drug were studied and various pharmacokinetic parameters were determined.     

Determination of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by reaction with 2,4-dinitro-β-henylethylamine

A method for the determination of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU) in body fluids is described. After extraction from urine or plasma with diethyl ether, methyl is treated with 2,4-dinitro-β-phenylethylamine to. The urea is separated of the amine and treated with trifluacetic anhydride; the trifluoroacetyl derivative is quantified by gas chromatography. Calibration graphs were linear urine, plasma and aqueous standards of metal-CCNU over the range 0.4–2.0 μg ml. The limits of detection for methyl-CCNU are in urine and 0.08 μg ml^?1 in plasma.     

Cathodic stripping voltammetry of pipemidic acid and ofloxacin in pharmaceutical dosages and human urine

Sensitive cathodic stripping voltammetric methods have been developed for two quinolone antibacterial drugs, pipemidic acid (PIP) and ofloxacin (OFL) using hanging mercury drop electrode as working electrode vs. Ag/AgCl reference electrode. The methods were developed for the determination of drugs individually as well as simultaneously. 0.1 M and 0.01 M hydrochloric acid was used as medium for PIP and OFL, respectively, 0.1 M potassium chloride was used as base electrolyte. Reduction waves were observed for PIP within ?700 mV to ?800 mV and for OFL within ?1100 mV to ?1200 mV. Linear calibration ranges for PIP and OFL were observed within 10–100 μg ml^?1 with detection limits of 50 ng ml^?1 and 1 μg ml^?1, respectively. Relative standard deviations (RSD) for the analysis of 10 gµg ml^?1 of PIP and OFL (n = 6) were 0.5% and 1.4%, respectively. The presence of glucose, lactose, sorbitol, gum arabic, starch, magnesium stearate, methylparaben and propylparaben did not affect the determinations of both PIP and OFL. The methods were used for the analysis of pharmaceutical preparations and the results indicated relative deviation of 0.5–5.5% from labeled values with RSD within 0.49–2.5%. PIP and OFL could also be determined simultaneously, and were determined from spiked human urine.     

Fluorimetric determination of danthron in pharmaceutical tablets and in urine

A simple, rapid determination is reported for danthron (1,8-dihydroxyanthraquinone) in pharmaceutical tablets. In a flow-injection system, danthron is reduced by sodium dithionite in $\text{1}\text{1}$ methanol/borate buffer to give a fluorescent complex. Linearity ranges from 30 μg ml^?1 to below 0.1 μg ml^?1. In urine samples, danthron is separated from other fluorescing species by reversed-phase high-performance liquid chromatography before its reduction by dithionite in a post-column reactor. Urine preparation requires no extraction. Spiked urine samples were studied in the working range of 0.02–2.0 μg ml^?1 danthron.     

Drug screening in human plasma by cloud-point extraction and HPLC

Cloud-point extraction (CPE) with RP-HPLC/DAD detection was used to develop a screen for six model basic drugs (paracetamol, promazine, amitriptyline, nortriptyline, clomipramine and chlorpromazine) in human plasma. These drugs’ varied hydrophobicities entail different affinities for the micelle-rich phase and CPE extraction efficiencies. Extraction recovery (except paracetamol) was above 80% and reproducibility (RSD%) ranged from 2.88 to 10.26 intraday and from 3.12 to 12.33 interday. The limits of detection were: 0.125 μg mL^?1 (promazine and chlorpromazine), 0.25 μg mL^?1 (amitriptyline and nortriptyline) and 0.5 μg mL^?1 (paracetamol and clomipramine). The method was linear over the ranges: 0.125–1.0 μg mL^?1 (promazine and chlorpromazine), 0.25–1.0 μg mL^?1 (amitriptyline and nortriptyline), 0.5–1.0 μg mL^?1 (clomipramine) and 0.5–10 μg mL^?1 (paracetamol). The procedure is a good alternative to the SPE or LLE sample preparation usually used.     

Amperometric determination of formaldehyde via the hexacyanoferrate(III) -coupled dehydrogenase reaction

An enzymatic method with amperometric detection was developed for the determination of formaldehyde. Formaldehyde is first oxidized by reaction with NAD⁺ in the presence of formaldehyde dehydrogenase. The resulting NADH is then oxidized by hexacyanoferrate(III) in the presence of diaphorase to produce hexacyanoferrate(II). The anodic current generated by oxidation of the hexacyanoferrate(II) at the surface of a glassy carbon working electrode, held at a potential of 0.40 V vs. an Ag/AgCl reference electrode, is measured. The effects of solution conditions are examined and a linear relationship between rate of current change and formaldehyde concentration is obtained from 0.01 to 0.5 μg ml^?1 with a correlation coefficient of 0.9998. The relative standard deviation for the proposed method is 6.4% at 0.01 μg ml^?1 formaldehyde and 0.88% at 0.5 μg ml^?1.     

Simultaneous Determination of Valsartan and Hydrochlorothiazide in Tablets by High-Performance Liquid Chromatography

ABSTRACT

A method for the simultaneous determination of valsartan and hydrochlorothiazide in tablets is described. The procedure, based on the use of reversed-phase high-performance liquid chromatography, is linear in the concentration range 5.0-10.0 μg ml^?1 for valsartan and 0.5-2.0 μg ml^?1 for hydrochlorothiazide, is simple and rapid and allows accurate and precise results. The limit of detection was 1.0 μg ml^?1 for valsartan and 0.05 μg ml^?1 for hydrochlorothiazide.     

Determination of Molybdenum in Human Urine by Spectrophotometric Method using Thiazolylazo Compounds as Chromogenic Reagents

ABSTRACT

Four azo compounds based on diazotization of 2-aminobenzothiazole have been synthesized and characterized by elemental analysis as well as different spectroscopic techniques. The potentiality of the prepared compounds as new chromogenic reagents for the spectrophotometric determination of Mo⁶⁺ was studied by extensive investigation of optimum conditions favouring the formation of the coloured complexes. Beers law is obeyed in the concentration range 0.2-8.5 μg ml^?1 whereas Ringbom optimum concentration range was 0.8-7.5 μg ml^?1. The detection limit was 0.05 μg ml^?1. The molar absorptivity and Sandell sensitivity of the formed complexes are calculated. The effect of interfering ions on the determination of Mo⁶⁺ was investigated. The relative standard deviations for six replicate determinations of 5.0 μg ml^?1 of Mo⁶⁺ are 1.23, 1.47, 1.05 and 1.38 % using reagents I, II, III and IV, respectively. The proposed method has been applied to investigate the amount of Mo⁶⁺ in human urine samples. The molybdenum levels found between 0.5-2.1 μg/100 ml.     

Determination of ciclazindol in biological fluids by differential pulse polarography

A differential pulse polarographic method has been developed for determination of the antidepressant, 10-(m-chlorophenyl)-2,3,4,10-tetrahydropyrimido[1,2a]indol-10-ol hydrochloride in plasma and urine. The method involves solvent extraction of the drug from the plasma or urine, evaporation to dryness and dissolution of the residue in 10% methanolic 0.01 M tetraethylammonium chloride solution followed by differential pulse polarography. The mean recovery of the drug from plasma containing 0.5–5.0 μg ml^-1 is 80%; the coefficient of variation is 5.5% at the 1.0-μg ml^-1 (2.98 × 10^-6 M) level on 2-ml samples. The method is not subject to interference from the chemical degradation products and metabolites. The techniques described have been applied to the analysis of human plasma; the polarographic and gas Chromatographic results showed good agreement.     

Fluorimetric determination of mebendazole and flubendazole in pharmaceutical dosage forms after alkaline hydrolysis

The selective and very sensitive fluorimetric determination of mebendazole and flubendazole is based on alkaline hydrolysis and adsorption on Whatman 42 filter paper. Limits of detection are 0.1 μg ml^?1 and 0.5 μg ml^?1, respectively, with linear response sponse up to 10 μg ml^?1 and 50 μg ml^t?1. The fluorescence produced is very stable (λ_em = 460 nm) and the method is applicable to anthelmintic pharmaceutical preparations.     

Automated method for the determination of boron in water by flow-injection analysis with in-line preconcentration and spectrophotometric detection

A sensitive, automated method for the determination of boron in water samples is described, involving flow injection with on-line ion-exchange preconcentration and spectrophotometric detection of the azomethine-H—boron complex. The method is applicable to various water samples and is free from interferences, even in coloured samples. Detection limits of 5 μg l^?1 at 20 samples h^?1 and 1 μg l^?1 at 10 samples h^?1 with relative standard deviations of < 10% at 1–10 μg l^?1 and < 5%at 10–200 μg l^?1 levels of boron were achieved. The recoveries for spiked natural water samples ranged from 96 to 101%. The method compares favourably with inductively coupled plasma atomic emission spectrometry.     

Kinetic spectrophotometric determination of indium/gallium mixtures

A kinetic method is presented for the determination of 0.5–5 μg ml^?1 gallium based on its activating effect on the copper(II)-catalyzed oxidation of 4,4′-dihydroxybenzophenone thiosemicarbazone by hydrogen peroxide. The reaction is monitored spectrophotometrically at 415 nm. Two sets of reaction conditions are established; one for the direct determination of gallium, and another, in which indium affects the gallium response, for determination of indium. Mixtures of these cations can be determined at μg ml^?1 levels and in gallium/indium ratios from 7.5:1 to 1:1.6, with an accuracy and precision of ca. 4.5%.     

Enhancement of ruthenium determination by inductively coupled plasma/atomic emission spectrometry by addition of periodic acid

A sensitive method for the determination of ruthenium involving the formation of volatile species in solution and subsequent nebulization for inductively coupled plasma/atomic emission spectrometry is proposed. The sensitivity of the determination of ruthenium was increased by a factor of 70 with the addition of 1×10^?2 M periodic acid as an oxidizing agent. The detection limit was 5 ng ml^?1 of ruthenium and the calibration was linear over the range 0.01–0.5 μg ml^?1 of ruthenium. Serious interferences were not found except from reducing agents.     

A Fluorosensor with Immobilized Cyclodextrin As A Substrate

Abstract

A flow-through optosensor for phenylalanine and tyrosine is described in this paper. The sensor is developed in conjunction with a flow-injection analysis system and uses immobilized β-cyclodextrin as the sensing agent. The analytical performance characteristics of the proposed sensor for analysis of very low levels of phenylalanine and tyrosine were as follows: the detection limits for phenylalanine and tyrosine were 0.20 μg ml^?1 and 8.9 ng ml^?1, respectively. The observed relative standard deviations were 1.03% for 50 μg ml^?1 of phenylalanine (n = 7) and 3.6% for 0.1 μg ml^?1 of tyrosine (n = 7), respectively.     

Cetyl‐alcohol‐reinforced hollow fiber solid/liquid‐phase microextraction and HPLC–DAD analysis of ezetimibe and simvastatin in human plasma and urine

A new cetyl‐alcohol‐reinforced hollow fiber solid/liquid‐phase microextraction (CA–HF–SLPME) followed by high‐performance liquid chromatography–diode array detection (HPLC–DAD) method was developed for simultaneous determination of ezetimibe and simvastatin in human plasma and urine samples. To prepare the CA–HF–SLPME device, the cetyl‐alcohol was immobilized into the pores of a 2.5 cm hollow fiber micro‐tube and the lumen of the micro‐tube was filled with 1‐octanol with the two ends sealed. Afterwards, the prepared device was introduced into 10 mL of the sample solution containing the analytes with agitation. Under optimized conditions, calibration curves plotted in spiked plasma and urine samples were linear in the ranges of 0.363–25/0.49–25 μg L^?1 for ezetimibe/simvastatin and 0.193–25/0.312–25 μg L^?1 for ezetimibe/simvastatin in plasma and urine samples, respectively. The limit of detection was 0.109/0.174 μg L^?1 for ezetimibe/simvastatin in plasma and 0.058/0.093 μg L^?1 for ezetimibe/simvastatin in urine. As a potential application, the proposed method was applied to determine the concentration of selected analytes in patient plasma and urine samples after medication and satisfactory results were achieved. In comparison with reference methods, the CA–HF–SLPME–HPLC–DAD method demonstrates considerable potential in the biopharmaceutical analysis of selected drugs.     

Batch and flow-injection determination of ethylenediamine in pharmaceutical preparations

the ethylenediamine/pyridine-2-carbaldehyde/copper(I) system is used in a new spectrophotometric method for the determination of ethylenediamine. The batch procedure involves the formation of an orange chelate between the Schiff's base and copper(I) ions at pH 8.5 (borate buffer) and measurement of the absorbances at 475 nm against water after 10/2-15 min; Beer's law is obeyed over the range 0.5/2-11.2 μg ml^?1 and the molar absorptivity is 6.21 × 10³ l mol^?1 cm^?1. Tolerance limits for different amines [36] and other organic compounds [12] are reported. In the optimized flow-injection system, ethylenediamine (1.4/2-84.6 μg ml^?1 is determined at a sample throughput of 55 h^?1. The method is sensitive and selective and is satisfactory for the determination of the diamine in aminophylline and pharmaceutical preparations (ethylenediamine contents from 0.031 to 3.23%) with relative errors ranging from ?7.4 to +11.1% and relative standard deviations of about 0.65% for both procedures.     

Indirect atomic absorption spectrometric determination of perchlorate by liquid-liquid extraction in a flow-injection system

The determination is based on the continuous liquid-liquid extraction of the copper(I)/6-methylpicolinealdehyde azine/perchlorate ion-pair into 4-methyl-2-pentanone in a flow-injection manifold. The organic fills a loop of an injector situated in an integrated feed system of an atomic absorption spectrometer. Measurement of the copper atomic absorption signal from the organic phase allows the indirect determination of 0.5–5 μg ml^?1 perchlorate, giving a 3-fold increase in sensitivity over the conventional spectrophotometric method. The detection limit is 70 ng ml^?1. The sampling frequency is 45 ± 5 h^?1. The method is highly selective, and has been used for the determination of perchlorate added to serum and urine samples.